Dr. Van Eyk has a longstanding record of excellence in applying cutting-edge analytical technologies to address clinically relevant biological hypotheses. Dr. Van Eyk is a Professor of Medicine at Cedars-Sinai Medical Center. In keeping with her research mission of bringing discovery to patient care, Dr. Van Eyk serves as Director of the Basic Science Research in the Barbra Streisand Woman’s Heart Center, Director of the Advanced Clinical Biosystems Research Institute, and co-director of the Cedars-Sinai Precision Health focused on in-hospital and population individualization of health care. Dr. Van Eyk is an international leader in the area of clinical proteomics and her lab remains focused on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods. These encompass data dependent acquisition- and data independent acquisition-mass spectrometry methods for discovery, as well as targeted multiple reaction monitoring (MRM, also known as SRM). Her laboratory is recognized for the rigor it applies to technical quality, control, and reproducibility of increasingly complex datasets that can address key clinical questions with improvements in throughput to enable continuous assessments of large healthy cohorts and clinical grade assays focusing on brain and cardiovascular diseases. Her list of achievements includes more than 300 published articles, over a 20 patents, and numerous research and leadership awards.